State Street’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

State Street’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-83,705	Closed	-$184K	–	5015
2022 Q2	$184K	Buy	83,705 +43,400	+108%	+$86.7K	﹤0.01%	4243
2022 Q1	$75K	Hold	40,305	–	–	﹤0.01%	4715
2021 Q4	$88K	Hold	40,305	–	–	﹤0.01%	4605
2021 Q3	$135K	Buy	40,305 +1,100	+3%	+$2.98K	﹤0.01%	4478
2021 Q2	$105K	Buy	+39,205	New	+$88.6K	﹤0.01%	4357

State Street's ETTX Position: Q3 2022 in Review

State Street sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 83,705 shares — an estimated $184K sold.

State Street first reported a position in ETTX in Q2 2021 and held it in 5 quarters. The position peaked at $184K in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

State Street reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
State Street sold 83,705 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $184K.
State Street first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2021 and held it in 5 quarters.
State Street's Entasis Therapeutics Holdings Inc. position peaked at $184K in Q2 2022.
0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.